GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Next Science Ltd (ASX:NXS) » Definitions » FCF Yield %

Next Science (ASX:NXS) FCF Yield % : -37.39 (As of Mar. 23, 2025)


View and export this data going back to 2019. Start your Free Trial

What is Next Science FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Next Science's Trailing 12-Month Free Cash Flow is A$-13.11 Mil, and Market Cap is A$35.06 Mil. Therefore, Next Science's FCF Yield % for today is -37.39%.

The historical rank and industry rank for Next Science's FCF Yield % or its related term are showing as below:

ASX:NXS' s FCF Yield % Range Over the Past 10 Years
Min: -84.79   Med: -9.53   Max: -4.53
Current: -37.39


During the past 7 years, the highest FCF Yield % of Next Science was -4.53%. The lowest was -84.79%. And the median was -9.53%.

ASX:NXS's FCF Yield % is ranked worse than
91.76% of 1032 companies
in the Drug Manufacturers industry
Industry Median: 0.145 vs ASX:NXS: -37.39

Next Science's FCF Margin % for the quarter that ended in Dec. 2024 was -27.52%.


Next Science FCF Yield % Historical Data

The historical data trend for Next Science's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Next Science FCF Yield % Chart

Next Science Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
FCF Yield %
Get a 7-Day Free Trial -6.89 -5.09 -12.35 -24.02 -40.19

Next Science Semi-Annual Data
Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -11.62 -19.93 -22.93 -23.58 -29.95

Competitive Comparison of Next Science's FCF Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Next Science's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Next Science's FCF Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Next Science's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Next Science's FCF Yield % falls into.



Next Science FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Next Science's FCF Yield % for the fiscal year that ended in Dec. 2024 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-13.504 / 33.5984
=-40.19%

Next Science's annualized FCF Yield % for the quarter that ended in Dec. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-5.031 * 2 / 33.5984
=-29.95%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Next Science FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Next Science FCF Yield % Related Terms

Thank you for viewing the detailed overview of Next Science's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Next Science Business Description

Traded in Other Exchanges
Address
264-278 George Street, Level 14, Australia Square, HWL Ebsworth, Sydney, NSW, AUS, 2000
Next Science Ltd is a medical technology company. It is engaged in the development and commercialization of its proprietary Xbio technology to reduce the impact of biofilm-based infections in human health. Xbio is a non-toxic technology with efficacy in eradicating both biofilm-based and free-floating bacteria. Its products include Bactisure, SURGX, XEPERIENCE and BLASTX. The company derives revenue from North America, New Zealand, and Australia.

Next Science Headlines

No Headlines